LGL Partners, LLC
- SEC CIK
- 0001653202
- Latest filing
- Jul 27, 2026
SABS holding history
SAB Biotherapeutics, Inc. in every 13F filed by LGL Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SABS overviewAll 13F holders of SABSFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −23,000−100.0% | Sold out | Holders |
| Q3 2023 | 23,000 | $14.5K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 23,000 | $19.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 23,000 | $10.1K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 23,000 | $13.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 23,000 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 23,000 | $33.0K | <0.1% | +23,000 | New | Holders |